Related Experiment Video
Updated: Dec 8, 2025

In Vivo CRISPR/Cas9 Screening to Simultaneously Evaluate Gene Function in Mouse Skin and Oral Cavity
Published on: November 2, 2020
In vivo CRISPR screens reveal potent driver mutations in head and neck cancers
Sampath Kumar Loganathan1, Daniel Schramek1,2
1Centre for Molecular and Systems Biology, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.
Abstract:
We have recently tested the transforming potential of 484 'long-tail' genes, which are recurrently albeit infrequently mutated in head and neck cancers (HNSCC). We identified 15 novel tumor suppressors and our top hits converge on regulating the NOTCH signaling pathway. Therapeutic approaches activating NOTCH signaling could be a promising strategy to treat two-thirds of human HNSCC patients.
Insights
Researchers identified 15 new tumor suppressor genes in head and neck cancers (HNSCC). These genes regulate the NOTCH signaling pathway, suggesting NOTCH activation as a potential therapy for many HNSCC patients.
Area of Science:
- Oncology
- Cancer Genomics
- Molecular Biology
Background:
- Head and neck cancers (HNSCC) exhibit complex genomic alterations.
- Identifying novel tumor suppressor genes is crucial for understanding HNSCC development.
- The NOTCH signaling pathway plays a significant role in various cancers.
Purpose of the Study:
- To investigate the transforming potential of understudied 'long-tail' genes in HNSCC.
- To identify novel tumor suppressor genes implicated in head and neck cancer.
- To determine the role of these genes in key cellular signaling pathways.
Main Methods:
- Genomic analysis of 484 'long-tail' genes recurrently mutated in HNSCC.
- Functional screening to assess the tumor-suppressive capabilities of identified genes.
- Pathway analysis to pinpoint convergence on critical signaling networks.
Main Results:
- Fifteen novel tumor suppressor genes were identified in HNSCC.
- The most significant hits converged on the regulation of the NOTCH signaling pathway.
- These findings highlight the importance of NOTCH signaling in HNSCC pathogenesis.
Conclusions:
- Targeting the NOTCH signaling pathway offers a promising therapeutic strategy for HNSCC.
- Activating NOTCH signaling could benefit a substantial proportion of head and neck cancer patients.
- The identified tumor suppressors provide new avenues for HNSCC research and treatment.
Related Concept Videos
Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
Cancers Originate from Somatic Mutations in a Single Cell
CRISPR
In-vitro Mutagenesis
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
CRISPR and crRNAs
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...

